PepGen Inc.

NASDAQ:PEPG

Biotechnology

Healthcare
$3.83 +5.29%

+$0.09 today

Market cap
$265.27M
Beta
1.93
P/E (TTM)
-1.6
EPS (TTM)
-$1.12
52W Low $1.01High $7.80

Volume 3.39M

Average 1.37M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$81.64M

FY 2025 · Annual

Investing Cash Flow

-$15.23M

FY 2025 · Annual

Financing Cash Flow

$107.98M

FY 2025 · Annual

+21.7% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(27.28M)(69.1M)(78.63M)(89.98M)(89.66M)
Depreciation & Amortization178K493K850K5.25M5.15M
Deferred Income Tax00000
Stock-Based Compensation1.53M4.76M7.05M11.46M10.61M
Change in Working Capital2.77M4.51M1.95M(5.25M)(6.22M)
Accounts Receivables(4.34M)4.18M26K00
Inventory00000
Accounts Payables2.51M(1.41M)(369K)722K(935K)
Other Working Capital4.61M1.73M2.29M(5.97M)(5.29M)
Other Non-Cash Items196K76K(220K)(3.86M)(1.51M)
Operating Cash Flow(22.6M)(59.27M)(69M)(82.37M)(81.64M)
Capital Expenditures(500K)(3.76M)(2.6M)(497K)(264K)
Acquisitions (Net)00000
Purchases of Investments00(29.4M)(145.17M)(93.97M)
Sales of Investments000108M79M
Other Investing Activities00000
Investing Cash Flow(500K)(3.76M)(32M)(37.67M)(15.24M)
Debt Repayment00000
Common Stock Issued0114.27M086.78M108.1M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.39M)(2.07M)(189K)1.97M0
Financing Cash Flow147.66M112.19M(189K)88.75M107.98M
Effect of Forex Changes33K(316K)286K(62K)(16K)
Net Change in Cash124.59M48.86M(100.9M)(31.35M)11.09M
Free Cash Flow(23.1M)(63.02M)(71.6M)(82.87M)(81.9M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$89.7M
+ D&A$5.1M
+ Stock-Based Comp$10.6M
+ Deferred Tax$0
- Working Capital-$6.2M
- Other Non-Cash-$1.5M
= Operating Cash Flow-$81.6M
- Capex-$264.0K
= Free Cash Flow-$81.9M

Analysis

FY2025 free cash flow is -$81.9M. FCF conversion is 91.3% of net income. Operating cash flow was -$81.6M, with capex of -$264.0K. The largest bridge item is Stock-Based Comp at $10.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
424B5424B5 filingNov 12, 2026
8-KCurrent reportNov 12, 2026
424B5424B5 filingNov 10, 2026
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026

Does PEPG generate free cash flow?

PepGen Inc. (PEPG) generated -$81.90M of free cash flow in fiscal 2025.

How much operating cash flow does PEPG produce?

Operating cash flow was -$81.64M, before capital expenditures of $264,000.00.